- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/537 - Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
Patent holdings for IPC class G01N 33/537
Total number of patents in this class: 307
10-year publication summary
|
9
|
26
|
18
|
21
|
27
|
15
|
36
|
20
|
21
|
0
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
14 |
| President and Fellows of Harvard College | 5792 |
9 |
| Genzyme Corporation | 1205 |
6 |
| Terumo Kabushiki Kaisha | 5216 |
4 |
| Cytosed, Inc. | 4 |
4 |
| MedImmune Limited | 627 |
4 |
| Swiss Analyze Bacteria AG | 4 |
4 |
| FUJIFILM Corporation | 27102 |
3 |
| The Trustees of Columbia University in the City of New York | 3440 |
3 |
| University of Florida Research Foundation, Inc. | 3883 |
3 |
| Banyan Biomarkers, Inc. | 42 |
3 |
| Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1657 |
3 |
| National Jewish Health | 157 |
3 |
| Prometheus Laboratories Inc. | 91 |
3 |
| Siemens Healthcare Diagnostics Inc. | 1946 |
3 |
| Spring Bioscience Corporation | 18 |
3 |
| Miltenyi Biotec B.V. & Co. KG | 297 |
3 |
| Biora Therapeutics, Inc. | 95 |
3 |
| Novartis AG | 11238 |
2 |
| F. Hoffmann-La Roche AG | 7958 |
2 |
| Other owners | 225 |